R-2-Hydroxyglutarate (R-2HG), a well-established oncometabolite, could bind directly to the FTO protein and inhibit its m6A demethylase level, exhibiting intrinsic antitumor activity in R-2HG-sensitive AML [32]. This evidence concerns the gene FTO and acute myeloid leukemia.